US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cohen & Steers

76.33

+1.231.64%

Post-market: 76.330.00000.00%16:04 EDT

Volume:198.30K

Turnover:15.08M

Market Cap:3.89B

PE:24.96

High:76.85

Open:76.52

Low:75.40

Close:75.10

Loading ...

Overview Company News Filings

Press Release: Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins its Board of Directors

Press Release: Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Press Release: Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East

Market Chatter: LG CNS Secures Smart City Projects in NYC, Georgia

MT Newswires Live

Cohen & Steers Inc - Aum at March 31 of $87.6 Billion

THOMSON REUTERS

Cohen & Steers reports Q1 adjusted EPS 75c vs. 78c last quarter

COHEN & STEERS REPORTS RESULTS FOR FIRST QUARTER 2025

Press Release: Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments

Plus Therapeutics Presents New Data Highlighting Clinical Benefit and Safety of REYOBIQ in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases

CNS Pharmaceuticals files to sell 5.22M shares of common stock, warrants

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cohen & Steers Is Maintained at Outperform by Evercore ISI Group

Press Release: NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its Ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

Cohen & Steers, Inc. to Release First Quarter 2025 Results on April 16, 2025

CNS Pharmaceuticals Advances TPI 287 for Glioblastoma

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CNS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNS\",,,,,undefined,":{"symbol":"CNS","market":"US","secType":"STK","nameCN":"Cohen & Steers","latestPrice":76.33,"timestamp":1749240000000,"preClose":75.1,"halted":0,"volume":198296,"hourTrading":{"tag":"盘后","latestPrice":76.33,"preClose":76.33,"latestTime":"16:04 EDT","volume":3090,"amount":235859.7,"timestamp":1749240257336},"delay":0,"floatShares":27569691,"shares":50979157,"eps":3.05822,"marketStatus":"Closed","change":1.23,"latestTime":"06-06 16:00:00 EDT","open":76.52,"high":76.85,"low":75.4,"amount":15081767.037055,"amplitude":0.019308,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.05822,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1092369600000,"exchange":"NYSE","adjPreClose":75.1,"dividendRate":0.031311,"preHourTrading":{"tag":"盘前","latestPrice":75.1,"preClose":75.06,"latestTime":"09:17 EDT","volume":14,"amount":1051.3999999999999,"timestamp":1749215822575},"postHourTrading":{"tag":"盘后","latestPrice":76.33,"preClose":76.33,"latestTime":"16:04 EDT","volume":3090,"amount":235859.7,"timestamp":1749240257336},"volumeRatio":1.317478,"impliedVol":0.0254,"impliedVolPercentile":0.008},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNS\",,,,,undefined,":{"symbol":"CNS","floatShares":27569691,"roa":"14.72%","roe":"30.76%","lyrEps":3.000753,"volumeRatio":1.317478,"shares":50979157,"dividePrice":2.39,"high":76.85,"amplitude":0.019308,"preClose":75.1,"low":75.4,"week52Low":67.96,"pbRate":"7.66","psRate":"7.35","week52High":110.67,"institutionHeld":0.6131,"latestPrice":76.33,"eps":3.05822,"divideRate":0.031311,"volume":198296,"delay":0,"ttmEps":3.05822,"open":76.52,"prevYearClose":92.34,"prevWeekClose":76.84,"prevMonthClose":76.84,"prevQuarterClose":80.25,"fiveDayClose":76.84,"twentyDayClose":79.96,"sixtyDayClose":77.07},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529041965","title":"Press Release: Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2529041965","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529041965?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:00","pubTimestamp":1745409600,"startTime":"0","endTime":"0","summary":"HOUSTON, April 23, 2025  -- Plus Therapeutics, Inc.  , a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system  cancers, announces the appointment of Kyle Guse, J.D., M.B.A. to the Company's Board of Directors where he will serve as chair of the Audit Committee and on the Compensation Committee.\"Kyle's decades of financial, transactional and operational experience in our industry will make an immediate and positive impact to Plus' board of directors,\" said Marc H. Hedrick, M.D., Plus Therapeutics President and Chief Executive Officer. \"Furthermore, in his role as audit chair, Kyle will be a force in the successful execution of Plus' ambitious business plan and driving stockholder value.\". Headquartered in Houston, Texas, Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the potential","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","PSTV","BK4588","TM","03160","BK4007","BK4604","BK4585","BK4099","BK4139","BK4135","LENZ","BK4555"],"gpt_icon":0},{"id":"2529509756","title":"Press Release: Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2529509756","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529509756?lang=en_us&edition=fundamental","pubTime":"2025-04-23 19:30","pubTimestamp":1745407800,"startTime":"0","endTime":"0","summary":"NEW YORK, April 23, 2025  -- Anavex Life Sciences Corp.  , a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system  disorders, today announced the appointment of Professor Dr. Audrey Gabelle, MD, PhD, a specialist of predictive, personalized medicine and digital health in Alzheimer' disease and related disorders, to the Anavex Scientific Advisory Board.Dr. Audrey Gabelle is a Professor of Neurology, MD, PhD, Neurologist and Doctor in Neurosciences at the Memory Resources Research Center, the Rare and Early Dementia Reference Center and the European Neurodegenerative Excellence Center of Montpellier University. Dr. Gabelle is also researcher at the Montpellier Institute of Neurosciences and member of the European Alzheimer's Disease Consortium.\"I'm thrilled to join Anavex's Scientif","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MD","R","CNS","BK4196","AVXL","BK4135","BK4139","BK4022","BK4232"],"gpt_icon":0},{"id":"2529261372","title":"Axsome Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2529261372","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529261372?lang=en_us&edition=fundamental","pubTime":"2025-04-22 19:00","pubTimestamp":1745319600,"startTime":"0","endTime":"0","summary":"NEW YORK, April 22, 2025  -- Axsome Therapeutics, Inc. , a biopharmaceutical company leading a new era in the treatment of central nervous system  disorders, today announced that it will participate in four upcoming investor conferences in May:. The Citizens 2025 Life Sciences ConferenceThe Company will present on Wednesday, May 7, 2025, at 1:30 p.m. ET in New York, NY. BofA Securities 2025 Health Care ConferenceThe Company will present on Tuesday, May 13, 2025, at 3:00 p.m. PT in Las Vegas, NV. 2025 RBC Capital Markets Global Healthcare ConferenceThe Company will present on Tuesday, May 20, 2025, at 3:05 p.m. ET in New York, NY. Mizuho Neuro & Ophthalmology Summit 2025The Company will participate in investor meetings on Wednesday, May 21, 2025, in New York, NY. Live webcasts of the presentations at the Citizens, BofA, and RBC conferences can be accessed on the “Webcasts & Presentations” page of the “Investors” section of the Company’s website at axsome.com. Replays of the webcasts wil","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/axsome-therapeutics-participate-upcoming-investor-110000675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AXSM","CNS","BK4585","BK4505","BK4007","BK4135"],"gpt_icon":0},{"id":"2529035832","title":"Press Release: Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2529035832","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529035832?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:30","pubTimestamp":1745267400,"startTime":"0","endTime":"0","summary":"Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development. Dr. Moore joins Cassava as Senior Vice President, Clinical Development, effective April 28, 2025. He will be responsible for advancing the clinical evaluation of simufilam in new potential indications, including TSC. Dr. Moore will build on an established track record of working in leading global pharmaceutical companies to advance novel compounds for the treatment of CNS disorders.Jack Moore is an accomplished biopharmaceutical executive with extensive drug development expertise in CNS and neurodegenerative diseases including Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis, and other neuro-immunologic and oncologic disorders. He has a history of building and executing clinical development strategies and publication plans, as well as engaging with key opinion leaders, advisory boards, patient advocates, and medic","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4135","BK4547","SAVA","BK4585","BK4588","CNS"],"gpt_icon":0},{"id":"2529870834","title":"Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East","url":"https://stock-news.laohu8.com/highlight/detail?id=2529870834","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529870834?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:30","pubTimestamp":1745235000,"startTime":"0","endTime":"0","summary":"NEW YORK, April 21, 2025  -- Anavex Life Sciences Corp.  , a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system  disorders, today announced that Marwan Noel Sabbagh, MD, Professor of Neurology at Barrow Neurological Institute and Chairman of Anavex’s Scientific Advisory Board gave an oral presentation titled, “Oral Blarcamesine Novel Mechanism for Alzheimer Disease: Autophagy Restoration through Upstream SIGMAR1 Activation Clinical Efficacy Phase IIb/III Trial” at the 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/anavex-life-sciences-announces-presentation-113000019.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","AVXL","BK4135","UAE","ADRD","CNS"],"gpt_icon":0},{"id":"2529184596","title":"Market Chatter: LG CNS Secures Smart City Projects in NYC, Georgia","url":"https://stock-news.laohu8.com/highlight/detail?id=2529184596","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529184596?lang=en_us&edition=fundamental","pubTime":"2025-04-21 13:05","pubTimestamp":1745211950,"startTime":"0","endTime":"0","summary":"LG CNS  secured its first US public sector smart city contract, partnering with the New York City Economic Development Corp. to install electric vehicle charging stations and a control system at the Brooklyn Army Terminal.The deal comprises Level 3 ultra-fast chargers and energy storage systems, Pulse News reported Friday.In a separate project, LG CNS will build smart street lighting in Hogansville, Georgia, with plans to expand to nearby cities, it said.Shares of LG CNS rose nearly 1% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4233","BK4211","CHCO","BK4160","NYC","BK4135","CNS"],"gpt_icon":0},{"id":"2528720847","title":"Cohen & Steers Inc - Aum at March 31 of $87.6 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2528720847","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528720847?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:39","pubTimestamp":1744835951,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QU0ZU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4135","CNS"],"gpt_icon":0},{"id":"2528648208","title":"Cohen & Steers reports Q1 adjusted EPS 75c vs. 78c last quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2528648208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528648208?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:30","pubTimestamp":1744835440,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $134.5M vs. $139.8M last quarter. Net inflows of $222M. Published first on TheFly – the ultimate source for real-time, market-mo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cohen-steers-reports-q1-adjusted-eps-75c-vs-78c-last-quarter?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cohen-steers-reports-q1-adjusted-eps-75c-vs-78c-last-quarter?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNS"],"gpt_icon":0},{"id":"2528208282","title":"COHEN & STEERS REPORTS RESULTS FOR FIRST QUARTER 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528208282","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528208282?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:19","pubTimestamp":1744834740,"startTime":"0","endTime":"0","summary":"The company will host a conference call tomorrow, Thursday, April 17, 2025, at 10:00 a.m.  to discuss these results via webcast and telephone. Hosting the call will be chief executive officer, Joseph Harvey, chief financial officer, Raja Dakkuri, and president and chief investment officer, Jon Cheigh.About Cohen & Steers. Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, Tokyo and Singapore.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/cohen-steers-reports-results-first-201900049.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cohen-steers-reports-results-first-201900049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CNS","FOR","ET","BK4581","BK4024","BK4585","BK4135","BK4144","BK4588","BK4590","BK4561"],"gpt_icon":0},{"id":"2527942124","title":"Press Release: Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2527942124","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527942124?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:30","pubTimestamp":1744716600,"startTime":"0","endTime":"0","summary":"- Vikram Ranade, PhD, appointed as chief business officer -. - Ranjan Batra, PhD, appointed as chief scientific officer -. - Oxana Beskrovnaya, PhD, transitioning to chief innovation officer -. WALTHAM, Mass., April 15, 2025  -- Dyne Therapeutics, Inc. , a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced the appointments of Vikram  Ranade, PhD, as chief business officer  and Ranjan  Batra, PhD, as chief scientific officer  of Dyne. Dr. Ranade will lead business development, corporate strategy and strategic partnerships to support the company's late-stage clinical and commercialization plans. Dr. Batra will lead the company's research strategy, pipeline development and activities supporting clinical development. Effective April 28, 2025, Oxana Beskrovnaya, PhD, will transition from CSO to chief innovation officer  responsible for driving Dyne's comprehensive innovation strategy to","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4194","CNS","BK4139","BK4588","03160","BK4555","BK4007","BK4099","TM","BK4223","CIO","DYN","LENZ","BK4135","BK4585","BK4604"],"gpt_icon":0},{"id":"2527163224","title":"Plus Therapeutics Presents New Data Highlighting Clinical Benefit and Safety of REYOBIQ in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2527163224","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527163224?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:30","pubTimestamp":1744716600,"startTime":"0","endTime":"0","summary":"New abstract published ahead of the Nuclear Medicine and Neurooncology Conference shows promise for REYOBIQ. Finally, RNA sequencing of LM cells showed early induction of apoptosis, with an innate immune response followed by an increase in T cells and an adaptive immune response by Day 28. Further details can be found here; the Company will provide additional data and explanation following the meeting.About Leptomeningeal Metastases LM is a rare complication of cancer in which the primary cancer spreads to the cerebrospinal fluid  and leptomeninges surrounding the brain and spinal cord. All malignancies originating from solid tumors, primary brain tumors, or hematological malignancies have this LM complication potential with breast cancer as the most common cancer linked to LM, with 3-5% of breast cancer patients developing LM. Additionally, lung cancer, GI cancers and melanoma can also spread to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/plus-therapeutics-presents-data-highlighting-113000997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","PSTV","BK4135","CNS","BK4007","BK4202","BK4139","NCI","CSF"],"gpt_icon":0},{"id":"2527014798","title":"CNS Pharmaceuticals files to sell 5.22M shares of common stock, warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2527014798","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527014798?lang=en_us&edition=fundamental","pubTime":"2025-04-15 05:10","pubTimestamp":1744665031,"startTime":"0","endTime":"0","summary":"A.G.P. is sole placement agent. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cns-pharmaceuticals-files-to-sell-5-22m-shares-of-common-stock-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cns-pharmaceuticals-files-to-sell-5-22m-shares-of-common-stock-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNS","BK4135"],"gpt_icon":0},{"id":"2527141422","title":"Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2527141422","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527141422?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:30","pubTimestamp":1744662600,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., April 14, 2025  -- Dyne Therapeutics, Inc. , a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that it has granted inducement equity awards to three new employees. The awards were approved by Dyne’s Compensation Committee and made as an inducement material to the new employees’ acceptance of employment with Dyne in accordance with Nasdaq Listing Rule 5635.The inducement equity awards are subject to the terms and conditions of award agreements covering the grants and Dyne’s 2024 Inducement Stock Incentive Plan.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dyne-therapeutics-reports-inducement-grants-203000351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2210149790.SGD","BK4588","LENZ","IE00BGHQF748.EUR","BK4585","BK4007","BK4112","LU2095319765.USD","BK4505","CNS","IE00BKPKM429.USD","DYN","BK4139",".IXIC","LU2210150020.SGD","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4135"],"gpt_icon":0},{"id":"2526940696","title":"Cohen & Steers Is Maintained at Outperform by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2526940696","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526940696?lang=en_us&edition=fundamental","pubTime":"2025-04-11 23:27","pubTimestamp":1744385220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 11, 2025 11:27 ET (15:27 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS"],"gpt_icon":0},{"id":"2526631975","title":"Press Release: NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President","url":"https://stock-news.laohu8.com/highlight/detail?id=2526631975","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526631975?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:05","pubTimestamp":1744286700,"startTime":"0","endTime":"0","summary":"NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company's New President. CALABASAS, Calif., April 10, 2025  -- NeOnc Technologies Holdings, Inc. , a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system  cancers and disorders, today announced that Executive Chairman Amir Heshmatpour has been appointed to serve as President of the Company. Heshmatpour will retain his role as Executive Chairman, while taking on day-to-day leadership responsibilities to accelerate the Company's strategic and clinical initiatives.\"Amir's appointment as President reflects our commitment to strong, visionary leadership as NeOnc advances its clinical programs,\" said Dr. Thomas Chen, CEO of NeOnc. \"His extensive experience in building and scaling companies, coupled with his deep understanding of capital markets and business development, will be instrumental as we move forward.\"","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4585","BK4588","CNS","TM","BK4099","03160","BK4604","BK4555","BK4135","BK4007"],"gpt_icon":0},{"id":"2526718557","title":"TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2526718557","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526718557?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:30","pubTimestamp":1744284600,"startTime":"0","endTime":"0","summary":"NEW YORK, April  10, 2025  (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced the presentation of data yesterday highlighting BRIUMVI (ublituximab-xiiy) in patients with relapsing for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/10/3059147/8790/en/TG-Therapeutics-Announces-Data-Presentations-for-BRIUMVI-in-Multiple-Sclerosis-at-the-American-Academy-of-Neurology-2025-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","LU1989772923.USD","LU2357305700.SGD","LU0971096721.USD","LU2089283258.USD","LU1363072403.SGD","BK4139","LU0158827781.USD","BK4534","LU1668664300.SGD","LU2089284900.SGD","LU1548497426.USD","LU1720051017.SGD","LU0106261372.USD","LU1989772840.SGD","PML","TG","LU2023251221.USD","LU0225283273.USD","BK4153","IE00BZ1G4Q59.USD","BK4201","LU1162221912.USD","BK4107","BK4127","TGTX","BK4516","LU1732799900.SGD","IE00BKVL7J92.USD","BK4588","LU1732800096.USD","BK4581","EC","LU0314104364.USD","LU0267386448.USD","BK4090","LU2347655156.SGD","LU2271345857.HKD","BK4135","LU0795875169.SGD","BK4117","LU0158827948.USD","LU1074936037.SGD","LU2111349929.HKD","LU0006306889.USD","LU0320765646.SGD","LU2133065610.SGD","AFG","CNS","LU2028103732.USD"],"gpt_icon":0},{"id":"2526255278","title":"Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its Ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2526255278","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526255278?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:02","pubTimestamp":1744282920,"startTime":"0","endTime":"0","summary":"–SRC recommended that the trial escalate to the next dose level of 30mg capsule –。“We are seeing substantial enrollment demand and have already identified Cohort 6 patients. In addition, we continue to observe substantial exposure levels of PAS-004, and remain excited about the possibility of delivering relevant pERK inhibition below the no observed adverse effect levels  as we modeled and observed during our previously conducted nine-month chronic toxicity studies. The on label rash rate for both approved MEKi for NF1 exceeds 80% which leads to patients discontinuing who otherwise should remain on treatment for longer periods of time”, stated Dr. Tiago Reis Marques, Chief Executive Officer of Pasithea. “We will provide additional safety, pharmacokinetic  and pharmacodynamic  data over the next several weeks.”This press release contains statements that constitute “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Ac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pasithea-therapeutics-announces-positive-safety-110200309.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4231","BK4023","KTTAW","CNS","BK4139","BK4181","IE00B19Z4B17.USD","BK4135","AEIS","BK4007","PD","IE00B66KJ199.SGD","LU1169590202.USD","BK4080","BK4218","IE00B7SZL793.SGD","LU1169589451.USD","BK4157","IE0031619046.USD","KTTA","SRC","PK","LENZ"],"gpt_icon":0},{"id":"2526417273","title":"Cohen & Steers, Inc. to Release First Quarter 2025 Results on April 16, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2526417273","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526417273?lang=en_us&edition=fundamental","pubTime":"2025-04-10 05:30","pubTimestamp":1744234200,"startTime":"0","endTime":"0","summary":"The company will host a conference call on Thursday, April 17, 2025 at 10:00 a.m.  with access available via webcast and telephone. Chief executive officer, Joseph Harvey, chief financial officer, RajaDakkuri, and president and chief investment officer, JonCheigh, will review the company's operating results and outlook and be available for questions.About Cohen & Steers. Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, Tokyo and Singapore.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/cohen-steers-inc-release-first-213000216.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cohen-steers-inc-release-first-213000216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4590","BK4561","BK4581","ET","BK4135","CNS","BK4588","BK4585","BK4144"],"gpt_icon":0},{"id":"2526017310","title":"CNS Pharmaceuticals Advances TPI 287 for Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2526017310","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526017310?lang=en_us&edition=fundamental","pubTime":"2025-04-10 03:57","pubTimestamp":1744228644,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals ( ($CNSP) ) has shared an update. On April 9, 2025, CNS Pharmaceuticals announced its ongoing efforts to advance its lead produ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cns-pharmaceuticals-advances-tpi-287-for-glioblastoma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cns-pharmaceuticals-advances-tpi-287-for-glioblastoma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4135","CNS"],"gpt_icon":0},{"id":"2526352816","title":"Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2526352816","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526352816?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:00","pubTimestamp":1744196400,"startTime":"0","endTime":"0","summary":"Establishes framework for Makana’s kidney, heart and islet cell programs to utilize TNX-1500 for preclinical studies in support of regulatory filings for potential use in human recipients. “We are thrilled with this collaboration utilizing TNX-1500 as an importan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tonix-pharmaceuticals-makana-therapeutics-announce-110000667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1093756168.USD","LU1988902786.USD","LU2264538146.SGD","BK4588","LU1366333091.USD","LU0820562030.AUD","TKO","LU0640476718.USD","LU2756315664.SGD","LU1064131342.USD","BK4583","CNS","LU0345769631.USD","LU0354030438.USD","LU0943347566.SGD","LENZ","LU0157215616.USD","LU1366192091.USD","LU1551013342.USD","LU1551013425.SGD","BK4007","LU1261432733.SGD","LU0345770993.USD","BK4543","BK4566","LU0354030511.USD","BK4187","LU0820561818.USD","BK4585","LU1093756325.SGD","LU0820561909.HKD","BK4501","BK4108","BK4135","LU0149725797.USD","BK4206","LU0345770308.USD","LU2543165471.USD","LU0868494617.USD","BK4139","LU1280957306.USD","LU0689472784.USD","LU0345769128.USD","GE","TNXP","LU2756315318.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNS\",params:#limit:5,,,undefined,":[{"date":"2025-05-12","symbol":"CNS","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-12","defaultRemindTime":1747056600000,"name":"科恩-斯蒂尔斯金融","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-22","payableDate":"2025-05-12","currency":"USD","dateTimestamp":1747022400000,"payDate":"2025-05-22"},{"date":"2025-04-16","symbol":"CNS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":null,"defaultRemindTime":1744833600000,"name":null,"time":"Post Market","dateTimestamp":1744776000000,"actualEps":null},{"date":"2025-03-03","symbol":"CNS","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-03","defaultRemindTime":1741012200000,"name":"科恩-斯蒂尔斯金融","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-13","payableDate":"2025-03-03","currency":"USD","dateTimestamp":1740978000000,"payDate":"2025-03-13"},{"market":"US","date":"2025-01-22","symbol":"CNS","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1737522000000,"reportTimeType":"post","actualEps":0.78},{"date":"2024-11-18","symbol":"CNS","amount":0.59,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-18","defaultRemindTime":1731940200000,"name":"科恩-斯蒂尔斯金融","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-02","payableDate":"2024-11-18","currency":"USD","dateTimestamp":1731906000000,"payDate":"2024-12-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNS\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-01","recordDate":"2015-09-03","paymentDate":"2015-09-24","value":0.25,"currency":"USD"},{"executeDate":"2015-11-23","recordDate":"2015-11-25","paymentDate":"2015-12-16","value":0.75,"currency":"USD"},{"executeDate":"2016-03-07","recordDate":"2016-03-09","paymentDate":"2016-03-23","value":0.26,"currency":"USD"},{"executeDate":"2016-05-31","recordDate":"2016-06-02","paymentDate":"2016-06-23","value":0.26,"currency":"USD"},{"executeDate":"2016-08-30","recordDate":"2016-09-01","paymentDate":"2016-09-22","value":0.26,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1729137600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNS","date":"2025-06-05","current":24.587277,"percent":0.42916,"low":12.87852,"twenty":18.128761,"median":26.362523,"eighty":33.522419,"high":43.702499,"avg":26.250909,"sd":7.575665,"marketCap":3861161351},"quantilePoints":[{"date":"2020-06-12","current":26.802613,"twenty":17.91219,"median":21.888209,"eighty":25.860348,"marketCap":3287340424},{"date":"2020-06-19","current":27.643845,"twenty":17.91219,"median":21.929604,"eighty":25.901982,"marketCap":3390517630},{"date":"2020-06-26","current":25.143514,"twenty":17.91219,"median":21.929604,"eighty":25.953213,"marketCap":3083852046},{"date":"2020-07-02","current":26.319683,"twenty":17.91219,"median":21.967124,"eighty":25.986175,"marketCap":3228109065},{"date":"2020-07-10","current":26.152215,"twenty":17.91219,"median":22.016567,"eighty":25.992492,"marketCap":3207569158},{"date":"2020-07-17","current":26.362523,"twenty":17.91219,"median":22.08441,"eighty":26.071486,"marketCap":3233363460},{"date":"2020-07-24","current":25.339106,"twenty":17.91219,"median":22.145224,"eighty":26.111636,"marketCap":3036562493},{"date":"2020-07-31","current":23.987847,"twenty":17.91219,"median":22.179183,"eighty":26.111636,"marketCap":2874631600},{"date":"2020-08-07","current":24.132484,"twenty":17.91219,"median":22.253822,"eighty":26.111636,"marketCap":2891964508},{"date":"2020-08-14","current":24.666724,"twenty":17.935145,"median":22.29366,"eighty":26.111636,"marketCap":2955986191},{"date":"2020-08-21","current":24.654763,"twenty":17.935145,"median":22.345044,"eighty":26.111636,"marketCap":2954552870},{"date":"2020-08-28","current":24.499276,"twenty":17.958411,"median":22.424008,"eighty":26.111636,"marketCap":2935919693},{"date":"2020-09-04","current":23.969023,"twenty":18.000138,"median":22.496172,"eighty":26.111636,"marketCap":2872375785},{"date":"2020-09-11","current":23.263348,"twenty":18.099298,"median":22.501958,"eighty":26.111636,"marketCap":2787809831},{"date":"2020-09-18","current":22.832767,"twenty":18.192403,"median":22.546509,"eighty":26.111636,"marketCap":2736210266},{"date":"2020-09-25","current":22.155,"twenty":18.28108,"median":22.546509,"eighty":26.111636,"marketCap":2654988728},{"date":"2020-10-02","current":22.705187,"twenty":18.403976,"median":22.566583,"eighty":26.111636,"marketCap":2720921506},{"date":"2020-10-09","current":23.602231,"twenty":18.52773,"median":22.594828,"eighty":26.111636,"marketCap":2828420600},{"date":"2020-10-16","current":23.598244,"twenty":18.562573,"median":22.670837,"eighty":26.111636,"marketCap":2827942826},{"date":"2020-10-23","current":23.437391,"twenty":18.624451,"median":22.7205,"eighty":26.111636,"marketCap":2759143406},{"date":"2020-10-30","current":22.852978,"twenty":18.788661,"median":22.762059,"eighty":26.111636,"marketCap":2690343986},{"date":"2020-11-06","current":23.997588,"twenty":18.837817,"median":22.78812,"eighty":26.111636,"marketCap":2825092062},{"date":"2020-11-13","current":25.820138,"twenty":18.884452,"median":22.835905,"eighty":26.122473,"marketCap":3039649967},{"date":"2020-11-20","current":28.109489,"twenty":18.914144,"median":22.857139,"eighty":26.15386,"marketCap":3309161456},{"date":"2020-11-27","current":29.432766,"twenty":18.924936,"median":22.889551,"eighty":26.180357,"marketCap":3464942919},{"date":"2020-12-04","current":30.557145,"twenty":18.972497,"median":22.931471,"eighty":26.234833,"marketCap":3597309378},{"date":"2020-12-11","current":30.5815,"twenty":19.026142,"median":22.993772,"eighty":26.256821,"marketCap":3600176521},{"date":"2020-12-18","current":30.191823,"twenty":19.058337,"median":23.028301,"eighty":26.31233,"marketCap":3554302225},{"date":"2020-12-24","current":29.794029,"twenty":19.093721,"median":23.060018,"eighty":26.337042,"marketCap":3507472215},{"date":"2020-12-31","current":30.15935,"twenty":19.103205,"median":23.125625,"eighty":26.362312,"marketCap":3550479367},{"date":"2021-01-08","current":29.091799,"twenty":19.162181,"median":23.160033,"eighty":26.401457,"marketCap":3424802910},{"date":"2021-01-15","current":29.887389,"twenty":19.202231,"median":23.200606,"eighty":26.441488,"marketCap":3518462931},{"date":"2021-01-22","current":29.74126,"twenty":19.221971,"median":23.235659,"eighty":26.487931,"marketCap":3501260070},{"date":"2021-01-29","current":40.869698,"twenty":19.278958,"median":23.263348,"eighty":26.526288,"marketCap":3129964987},{"date":"2021-02-05","current":42.298578,"twenty":19.312251,"median":23.304616,"eighty":26.539566,"marketCap":3239394297},{"date":"2021-02-12","current":43.072294,"twenty":19.369502,"median":23.346381,"eighty":26.568376,"marketCap":3298648596},{"date":"2021-02-19","current":41.312714,"twenty":19.404944,"median":23.412011,"eighty":26.604536,"marketCap":3163892852},{"date":"2021-02-26","current":40.543706,"twenty":19.462875,"median":23.44404,"eighty":26.627953,"marketCap":3104999179},{"date":"2021-03-05","current":41.494638,"twenty":19.519205,"median":23.521823,"eighty":26.663067,"marketCap":3177825348},{"date":"2021-03-12","current":42.773043,"twenty":19.606366,"median":23.562376,"eighty":26.674223,"marketCap":3275730727},{"date":"2021-03-19","current":41.356092,"twenty":19.606366,"median":23.598948,"eighty":26.704024,"marketCap":3167214913},{"date":"2021-03-26","current":40.990833,"twenty":19.607142,"median":23.626615,"eighty":26.73796,"marketCap":3139241947},{"date":"2021-04-01","current":42.307023,"twenty":19.607142,"median":23.674531,"eighty":26.795994,"marketCap":3240041082},{"date":"2021-04-09","current":41.878789,"twenty":19.606366,"median":23.704202,"eighty":26.872012,"marketCap":3207245191},{"date":"2021-04-16","current":42.502248,"twenty":19.606366,"median":23.710206,"eighty":26.913332,"marketCap":3254992149},{"date":"2021-04-23","current":31.693219,"twenty":19.606366,"median":23.710206,"eighty":27.029751,"marketCap":3323477686},{"date":"2021-04-30","current":31.283888,"twenty":19.606366,"median":23.755094,"eighty":27.056161,"marketCap":3280553653},{"date":"2021-05-07","current":32.560979,"twenty":19.606366,"median":23.782134,"eighty":27.213028,"marketCap":3414474551},{"date":"2021-05-14","current":33.61905,"twenty":19.606366,"median":23.8007,"eighty":27.25402,"marketCap":3525428090},{"date":"2021-05-21","current":33.200422,"twenty":19.606366,"median":23.839623,"eighty":27.262589,"marketCap":3481529081},{"date":"2021-05-28","current":33.642052,"twenty":19.606366,"median":23.883463,"eighty":27.340067,"marketCap":3527840123},{"date":"2021-06-04","current":34.226291,"twenty":19.606366,"median":23.921975,"eighty":27.431277,"marketCap":3589105773},{"date":"2021-06-11","current":34.424104,"twenty":19.606366,"median":23.95944,"eighty":27.60508,"marketCap":3609849261},{"date":"2021-06-18","current":35.633985,"twenty":19.606366,"median":23.983072,"eighty":27.65774,"marketCap":3736722220},{"date":"2021-06-25","current":37.754727,"twenty":19.606366,"median":24.001439,"eighty":27.731371,"marketCap":3959111704},{"date":"2021-07-02","current":37.317698,"twenty":19.606366,"median":24.019996,"eighty":27.803594,"marketCap":3913283069},{"date":"2021-07-09","current":36.871468,"twenty":19.606366,"median":24.065621,"eighty":27.878924,"marketCap":3866489620},{"date":"2021-07-16","current":36.443639,"twenty":19.606366,"median":24.065621,"eighty":27.954254,"marketCap":3821625798},{"date":"2021-07-23","current":32.23161,"twenty":19.606366,"median":24.065621,"eighty":28.3446,"marketCap":3962006144},{"date":"2021-07-30","current":32.655452,"twenty":19.606366,"median":24.065621,"eighty":28.597983,"marketCap":4014106067},{"date":"2021-08-06","current":34.262979,"twenty":19.606366,"median":24.065621,"eighty":28.779046,"marketCap":4211708107},{"date":"2021-08-13","current":34.608395,"twenty":19.606366,"median":24.065621,"eighty":28.919847,"marketCap":4254167761},{"date":"2021-08-20","current":34.376809,"twenty":19.606366,"median":24.065621,"eighty":29.018684,"marketCap":4225700493},{"date":"2021-08-27","current":34.690824,"twenty":19.606366,"median":24.065621,"eighty":29.125292,"marketCap":4264300178},{"date":"2021-09-03","current":34.518116,"twenty":19.606366,"median":24.065621,"eighty":29.237927,"marketCap":4243070351},{"date":"2021-09-10","current":34.015692,"twenty":19.606366,"median":24.065621,"eighty":29.325721,"marketCap":4181310855},{"date":"2021-09-17","current":34.235502,"twenty":19.606366,"median":24.065621,"eighty":29.428707,"marketCap":4208330635},{"date":"2021-09-24","current":33.650649,"twenty":19.606366,"median":24.065621,"eighty":29.513948,"marketCap":4136438722},{"date":"2021-10-01","current":33.485791,"twenty":19.606366,"median":24.065621,"eighty":29.715133,"marketCap":4116173887},{"date":"2021-10-08","current":33.897936,"twenty":19.607142,"median":24.072911,"eighty":29.833679,"marketCap":4166835974},{"date":"2021-10-15","current":34.282604,"twenty":19.607142,"median":24.072911,"eighty":29.886999,"marketCap":4214120588},{"date":"2021-10-22","current":31.39397,"twenty":19.607142,"median":24.120524,"eighty":29.97263,"marketCap":4473703468},{"date":"2021-10-29","current":32.128708,"twenty":19.607919,"median":24.159112,"eighty":30.0979,"marketCap":4578405113},{"date":"2021-11-05","current":34.01649,"twenty":19.607919,"median":24.231662,"eighty":30.206436,"marketCap":4847417859},{"date":"2021-11-12","current":33.779441,"twenty":19.607919,"median":24.272267,"eighty":30.2663,"marketCap":4813637944},{"date":"2021-11-19","current":33.335822,"twenty":19.607919,"median":24.34227,"eighty":30.314228,"marketCap":4750421245},{"date":"2021-11-26","current":31.585048,"twenty":19.607919,"median":24.388858,"eighty":30.347179,"marketCap":4500932441},{"date":"2021-12-03","current":30.152596,"twenty":19.607919,"median":24.435486,"eighty":30.418709,"marketCap":4296805238},{"date":"2021-12-10","current":30.687649,"twenty":19.607919,"median":24.495428,"eighty":30.555834,"marketCap":4373051333},{"date":"2021-12-17","current":30.917925,"twenty":19.607919,"median":24.535811,"eighty":30.628753,"marketCap":4405866108},{"date":"2021-12-23","current":30.464146,"twenty":19.607919,"median":24.549254,"eighty":30.66128,"marketCap":4341201699},{"date":"2021-12-31","current":31.32768,"twenty":19.607919,"median":24.669496,"eighty":30.712708,"marketCap":4464257105},{"date":"2022-01-07","current":30.782468,"twenty":19.609472,"median":24.728839,"eighty":30.771039,"marketCap":4386563299},{"date":"2022-01-14","current":29.597225,"twenty":19.609472,"median":24.776362,"eighty":30.771039,"marketCap":4217663722},{"date":"2022-01-21","current":28.411981,"twenty":19.609472,"median":24.864401,"eighty":30.771039,"marketCap":4048764145},{"date":"2022-01-28","current":18.641168,"twenty":19.590769,"median":24.917596,"eighty":30.771039,"marketCap":3940668416},{"date":"2022-02-04","current":18.285055,"twenty":19.499836,"median":24.917596,"eighty":30.771039,"marketCap":3865387462},{"date":"2022-02-11","current":18.433435,"twenty":19.415099,"median":24.917596,"eighty":30.771039,"marketCap":3896754526},{"date":"2022-02-18","current":18.221137,"twenty":19.383827,"median":24.917596,"eighty":30.771039,"marketCap":3851875496},{"date":"2022-02-25","current":18.59767,"twenty":19.32955,"median":24.882576,"eighty":30.771039,"marketCap":3931473126},{"date":"2022-03-04","current":17.962167,"twenty":19.282693,"median":24.776362,"eighty":30.771039,"marketCap":3797130353},{"date":"2022-03-11","current":17.870066,"twenty":19.226995,"median":24.690202,"eighty":30.771039,"marketCap":3777660385},{"date":"2022-03-18","current":19.069692,"twenty":19.199701,"median":24.590174,"eighty":30.771039,"marketCap":4031256708},{"date":"2022-03-25","current":19.266364,"twenty":19.165812,"median":24.531824,"eighty":30.771039,"marketCap":4072832201},{"date":"2022-04-01","current":20.194336,"twenty":19.165812,"median":24.414953,"eighty":30.771039,"marketCap":4269001841},{"date":"2022-04-08","current":19.798278,"twenty":19.165812,"median":24.34446,"eighty":30.771039,"marketCap":4185276833},{"date":"2022-04-14","current":19.006163,"twenty":19.164835,"median":24.272267,"eighty":30.771039,"marketCap":4017826818},{"date":"2022-04-22","current":19.515002,"twenty":19.160428,"median":24.159112,"eighty":30.771039,"marketCap":3992027833},{"date":"2022-04-29","current":18.48702,"twenty":19.120759,"median":24.109263,"eighty":30.771039,"marketCap":3781741767},{"date":"2022-05-06","current":18.140576,"twenty":19.097352,"median":24.008501,"eighty":30.771039,"marketCap":3710872529},{"date":"2022-05-13","current":17.343267,"twenty":19.068709,"median":23.966477,"eighty":30.771039,"marketCap":3547773304},{"date":"2022-05-20","current":17.248065,"twenty":19.045263,"median":23.843035,"eighty":30.771039,"marketCap":3528298769},{"date":"2022-05-27","current":18.354779,"twenty":19.014348,"median":23.76195,"eighty":30.771039,"marketCap":3754690232},{"date":"2022-06-03","current":17.897813,"twenty":18.977944,"median":23.679147,"eighty":30.771039,"marketCap":3661212467},{"date":"2022-06-10","current":16.634018,"twenty":18.947577,"median":23.585518,"eighty":30.771039,"marketCap":3402688023},{"date":"2022-06-17","current":15.608226,"twenty":18.914815,"median":23.455654,"eighty":30.689004,"marketCap":3192849914},{"date":"2022-06-24","current":16.260354,"twenty":18.900025,"median":23.315177,"eighty":30.690358,"marketCap":3326250475},{"date":"2022-07-01","current":15.477324,"twenty":18.870215,"median":23.246645,"eighty":30.690358,"marketCap":3166072430},{"date":"2022-07-08","current":15.736747,"twenty":18.832714,"median":23.109571,"eighty":30.614098,"marketCap":3219140536},{"date":"2022-07-15","current":16.162773,"twenty":18.79571,"median":22.956359,"eighty":30.520819,"marketCap":3306289077},{"date":"2022-07-22","current":16.110583,"twenty":18.706811,"median":22.835905,"eighty":30.406577,"marketCap":3382239761},{"date":"2022-07-29","current":17.089231,"twenty":18.655675,"median":22.723109,"eighty":30.285785,"marketCap":3587696099},{"date":"2022-08-05","current":17.336827,"twenty":18.60341,"median":22.666493,"eighty":30.247635,"marketCap":3639676038},{"date":"2022-08-12","current":18.014155,"twenty":18.576102,"median":22.585581,"eighty":30.247635,"marketCap":3781873710},{"date":"2022-08-19","current":17.726522,"twenty":18.553033,"median":22.523144,"eighty":30.247635,"marketCap":3721488397},{"date":"2022-08-26","current":17.097906,"twenty":18.483674,"median":22.467927,"eighty":30.247635,"marketCap":3589517270},{"date":"2022-09-02","current":16.432175,"twenty":18.396609,"median":22.353732,"eighty":30.247635,"marketCap":3449754489},{"date":"2022-09-09","current":17.31595,"twenty":18.356371,"median":22.298527,"eighty":30.247635,"marketCap":3635293233},{"date":"2022-09-16","current":16.842748,"twenty":18.283229,"median":22.249478,"eighty":30.247635,"marketCap":3535949654},{"date":"2022-09-23","current":15.91722,"twenty":18.21193,"median":22.179183,"eighty":30.247635,"marketCap":3341645300},{"date":"2022-09-30","current":14.527769,"twenty":18.176655,"median":22.123505,"eighty":30.247635,"marketCap":3049945280},{"date":"2022-10-07","current":14.019773,"twenty":18.104175,"median":22.045314,"eighty":30.247635,"marketCap":2943297026},{"date":"2022-10-14","current":12.87852,"twenty":18.032153,"median":21.992474,"eighty":30.247635,"marketCap":2703703688},{"date":"2022-10-21","current":13.875906,"twenty":17.988291,"median":21.929604,"eighty":30.247635,"marketCap":2817169639},{"date":"2022-10-28","current":14.518731,"twenty":17.957216,"median":21.836807,"eighty":30.247635,"marketCap":2947679831},{"date":"2022-11-04","current":14.228587,"twenty":17.927938,"median":21.723866,"eighty":30.232415,"marketCap":2888773025},{"date":"2022-11-11","current":16.001462,"twenty":17.901888,"median":21.670268,"eighty":30.232415,"marketCap":3248712878},{"date":"2022-11-18","current":15.814339,"twenty":17.857353,"median":21.62555,"eighty":30.232415,"marketCap":3210721932},{"date":"2022-11-25","current":15.672797,"twenty":17.824307,"median":21.559545,"eighty":30.232415,"marketCap":3181985192},{"date":"2022-12-02","current":16.212576,"twenty":17.737907,"median":21.517024,"eighty":30.232415,"marketCap":3291574457},{"date":"2022-12-09","current":16.03025,"twenty":17.634502,"median":21.398073,"eighty":30.232415,"marketCap":3254557638},{"date":"2022-12-16","current":15.432895,"twenty":17.536399,"median":21.363322,"eighty":30.232415,"marketCap":3133278852},{"date":"2022-12-23","current":15.157007,"twenty":17.453772,"median":21.291372,"eighty":30.232415,"marketCap":3077266561},{"date":"2022-12-30","current":15.488072,"twenty":17.435795,"median":21.271518,"eighty":30.232415,"marketCap":3144481310},{"date":"2023-01-06","current":16.500458,"twenty":17.354712,"median":21.218395,"eighty":30.232415,"marketCap":3350022065},{"date":"2023-01-13","current":17.735954,"twenty":17.299707,"median":21.152857,"eighty":30.232415,"marketCap":3600859716},{"date":"2023-01-20","current":17.532037,"twenty":17.272433,"median":21.104444,"eighty":30.232415,"marketCap":3559459327},{"date":"2023-01-27","current":20.240915,"twenty":17.272433,"median":21.102629,"eighty":30.232415,"marketCap":3462046647},{"date":"2023-02-03","current":21.659032,"twenty":17.272433,"median":21.116232,"eighty":30.232415,"marketCap":3704604220},{"date":"2023-02-10","current":21.055336,"twenty":17.272433,"median":21.15785,"eighty":30.232415,"marketCap":3601346779},{"date":"2023-02-17","current":21.129374,"twenty":17.272433,"median":21.159455,"eighty":30.232415,"marketCap":3614010428},{"date":"2023-02-24","current":20.698656,"twenty":17.272433,"median":21.159455,"eighty":30.232415,"marketCap":3540339494},{"date":"2023-03-03","current":20.580952,"twenty":17.272433,"median":21.159455,"eighty":30.232415,"marketCap":3520207189},{"date":"2023-03-10","current":18.634532,"twenty":17.272433,"median":21.15785,"eighty":30.232415,"marketCap":3187287608},{"date":"2023-03-17","current":18.169458,"twenty":17.272433,"median":21.116232,"eighty":30.232415,"marketCap":3107740452},{"date":"2023-03-24","current":17.469835,"twenty":17.272433,"median":21.115136,"eighty":30.232415,"marketCap":2988075455},{"date":"2023-03-31","current":18.362705,"twenty":17.273887,"median":21.10979,"eighty":30.224296,"marketCap":3140793856},{"date":"2023-04-06","current":17.72248,"twenty":17.272433,"median":21.115136,"eighty":30.232415,"marketCap":3031288379},{"date":"2023-04-14","current":17.659318,"twenty":17.270978,"median":21.115684,"eighty":30.240533,"marketCap":3020485148},{"date":"2023-04-20","current":18.415569,"twenty":17.270978,"median":21.115684,"eighty":30.240533,"marketCap":3026377819},{"date":"2023-04-28","current":17.701417,"twenty":17.269524,"median":21.116232,"eighty":30.248652,"marketCap":2909015447},{"date":"2023-05-05","current":16.207374,"twenty":17.258712,"median":21.116232,"eighty":30.248652,"marketCap":2663487472},{"date":"2023-05-12","current":16.342745,"twenty":17.216458,"median":21.122803,"eighty":30.25677,"marketCap":2685734018},{"date":"2023-05-19","current":16.937516,"twenty":17.1325,"median":21.129374,"eighty":30.263026,"marketCap":2783477447},{"date":"2023-05-26","current":16.037888,"twenty":17.093405,"median":21.143612,"eighty":30.269283,"marketCap":2635634371},{"date":"2023-06-01","current":16.262047,"twenty":17.038241,"median":21.15785,"eighty":30.275539,"marketCap":2672472347},{"date":"2023-06-09","current":18.405015,"twenty":17.00976,"median":21.159455,"eighty":30.288052,"marketCap":3024643395},{"date":"2023-06-16","current":18.36915,"twenty":17.00976,"median":21.159455,"eighty":30.288052,"marketCap":3018749319},{"date":"2023-06-23","current":17.173631,"twenty":16.999409,"median":21.167314,"eighty":30.322625,"marketCap":2822280115},{"date":"2023-06-30","current":17.421701,"twenty":16.956799,"median":21.19089,"eighty":30.357198,"marketCap":2863047475},{"date":"2023-07-07","current":17.176619,"twenty":16.955322,"median":21.194819,"eighty":30.374484,"marketCap":2822771288},{"date":"2023-07-14","current":19.140259,"twenty":16.955322,"median":21.194819,"eighty":30.374484,"marketCap":3145471956},{"date":"2023-07-21","current":22.272461,"twenty":16.9482,"median":21.240006,"eighty":30.381903,"marketCap":3210797966},{"date":"2023-07-28","current":22.401932,"twenty":16.944638,"median":21.281264,"eighty":30.385612,"marketCap":3229462540},{"date":"2023-08-04","current":21.798869,"twenty":16.944638,"median":21.362879,"eighty":30.385612,"marketCap":3142524917},{"date":"2023-08-11","current":22.605317,"twenty":16.944638,"median":21.393729,"eighty":30.385612,"marketCap":3258782486},{"date":"2023-08-18","current":21.616995,"twenty":16.944638,"median":21.462546,"eighty":30.385612,"marketCap":3116305941},{"date":"2023-08-25","current":21.323906,"twenty":16.944638,"median":21.480607,"eighty":30.385612,"marketCap":3074054276},{"date":"2023-09-01","current":22.213396,"twenty":16.941077,"median":21.556303,"eighty":30.389322,"marketCap":3202283166},{"date":"2023-09-08","current":21.569282,"twenty":16.941077,"median":21.60996,"eighty":30.389322,"marketCap":3109427763},{"date":"2023-09-15","current":21.882819,"twenty":16.941077,"median":21.616127,"eighty":30.389322,"marketCap":3154627219},{"date":"2023-09-22","current":21.061489,"twenty":16.941077,"median":21.621272,"eighty":30.389322,"marketCap":3036224297},{"date":"2023-09-29","current":21.156914,"twenty":16.941077,"median":21.621272,"eighty":30.389322,"marketCap":3049980653},{"date":"2023-10-05","current":20.373072,"twenty":16.941077,"median":21.621272,"eighty":30.389322,"marketCap":2936982014},{"date":"2023-10-13","current":19.302957,"twenty":16.962706,"median":21.62555,"eighty":30.393031,"marketCap":2782714307},{"date":"2023-10-20","current":19.766808,"twenty":17.094797,"median":21.635278,"eighty":30.394386,"marketCap":2603881679},{"date":"2023-10-27","current":19.173804,"twenty":17.14802,"median":21.654483,"eighty":30.398449,"marketCap":2525765228},{"date":"2023-11-03","current":20.624613,"twenty":17.21745,"median":21.654483,"eighty":30.398449,"marketCap":2716880317},{"date":"2023-11-10","current":19.788994,"twenty":17.261187,"median":21.654483,"eighty":30.398449,"marketCap":2606804215},{"date":"2023-11-17","current":21.859285,"twenty":17.306392,"median":21.660629,"eighty":30.398449,"marketCap":2879523600},{"date":"2023-11-24","current":21.113234,"twenty":17.347082,"median":21.667395,"eighty":30.398449,"marketCap":2781246344},{"date":"2023-12-01","current":21.818252,"twenty":17.382449,"median":21.672805,"eighty":30.398449,"marketCap":2874118351},{"date":"2023-12-08","current":23.530438,"twenty":17.431804,"median":21.701465,"eighty":30.398449,"marketCap":3099664654},{"date":"2023-12-15","current":27.555382,"twenty":17.450036,"median":21.745585,"eighty":30.398449,"marketCap":3629870450},{"date":"2023-12-22","current":27.365139,"twenty":17.496342,"median":21.810744,"eighty":30.398449,"marketCap":3604809750},{"date":"2023-12-29","current":28.827398,"twenty":17.527254,"median":21.852697,"eighty":30.399804,"marketCap":3797433171},{"date":"2024-01-05","current":26.820522,"twenty":17.571979,"median":21.883893,"eighty":30.40319,"marketCap":3533067353},{"date":"2024-01-12","current":25.46644,"twenty":17.607846,"median":21.929604,"eighty":30.40319,"marketCap":3354694133},{"date":"2024-01-19","current":24.690547,"twenty":17.644846,"median":21.986315,"eighty":30.406577,"marketCap":3252485787},{"date":"2024-01-26","current":26.760864,"twenty":17.711966,"median":22.045314,"eighty":30.40319,"marketCap":3453462775},{"date":"2024-02-02","current":27.042638,"twenty":17.738956,"median":22.116155,"eighty":30.40319,"marketCap":3489825360},{"date":"2024-02-09","current":26.34582,"twenty":17.7688,"median":22.15546,"eighty":30.40319,"marketCap":3399901671},{"date":"2024-02-16","current":27.141639,"twenty":17.80097,"median":22.213396,"eighty":30.40319,"marketCap":3502601403},{"date":"2024-02-23","current":27.30918,"twenty":17.835673,"median":22.249478,"eighty":30.40319,"marketCap":3524222400},{"date":"2024-03-01","current":28.224884,"twenty":17.840133,"median":22.284274,"eighty":30.399804,"marketCap":3642393114},{"date":"2024-03-08","current":29.072974,"twenty":17.854544,"median":22.345044,"eighty":30.399804,"marketCap":3751838236},{"date":"2024-03-15","current":26.943156,"twenty":17.854544,"median":22.410631,"eighty":30.399804,"marketCap":3476987362},{"date":"2024-03-22","current":29.203449,"twenty":17.862113,"median":22.484099,"eighty":30.399804,"marketCap":3768675948},{"date":"2024-03-28","current":29.116605,"twenty":17.870066,"median":22.523144,"eighty":30.399804,"marketCap":3757468730},{"date":"2024-04-05","current":28.065076,"twenty":17.868475,"median":22.583959,"eighty":30.40319,"marketCap":3621769977},{"date":"2024-04-12","current":27.869353,"twenty":17.868475,"median":22.609066,"eighty":30.40319,"marketCap":3596512181},{"date":"2024-04-19","current":25.6312,"twenty":17.868475,"median":22.695824,"eighty":30.40319,"marketCap":3274103832},{"date":"2024-04-26","current":27.635851,"twenty":17.870066,"median":22.753371,"eighty":30.399804,"marketCap":3530175929},{"date":"2024-05-03","current":27.556733,"twenty":17.870066,"median":22.836196,"eighty":30.399804,"marketCap":3520069499},{"date":"2024-05-10","current":29.163628,"twenty":17.870066,"median":22.943915,"eighty":30.399804,"marketCap":3725332736},{"date":"2024-05-17","current":29.183411,"twenty":17.870066,"median":23.090775,"eighty":30.399804,"marketCap":3727859756},{"date":"2024-05-24","current":28.221973,"twenty":17.870066,"median":23.209747,"eighty":30.399804,"marketCap":3605046589},{"date":"2024-05-31","current":27.054795,"twenty":17.870066,"median":23.285328,"eighty":30.399804,"marketCap":3455952415},{"date":"2024-06-07","current":27.822363,"twenty":17.870066,"median":23.445508,"eighty":30.399804,"marketCap":3554000787},{"date":"2024-06-14","current":28.154712,"twenty":17.868475,"median":23.529127,"eighty":30.40319,"marketCap":3596454721},{"date":"2024-06-21","current":28.269451,"twenty":17.866885,"median":23.600941,"eighty":30.406577,"marketCap":3611111437},{"date":"2024-06-28","current":28.00832,"twenty":17.862113,"median":23.655779,"eighty":30.416736,"marketCap":3577754774},{"date":"2024-07-05","current":28.550365,"twenty":17.862113,"median":23.741772,"eighty":30.416736,"marketCap":3646995119},{"date":"2024-07-12","current":29.808544,"twenty":17.862113,"median":23.829483,"eighty":30.416736,"marketCap":3807713585},{"date":"2024-07-15","current":30.034066,"twenty":17.862113,"median":23.84751,"eighty":30.416736,"marketCap":3836521612},{"date":"2024-08-02","current":33.347515,"twenty":17.848785,"median":23.979228,"eighty":30.525101,"marketCap":4259544743},{"date":"2024-08-09","current":32.935122,"twenty":17.848785,"median":24.052267,"eighty":30.630396,"marketCap":4206869033},{"date":"2024-08-16","current":33.287348,"twenty":17.848785,"median":24.123689,"eighty":30.714063,"marketCap":4251859581},{"date":"2024-08-23","current":33.750387,"twenty":17.848785,"median":24.183737,"eighty":30.826419,"marketCap":4311004459},{"date":"2024-08-30","current":34.755617,"twenty":17.848785,"median":24.299974,"eighty":30.970882,"marketCap":4439404451},{"date":"2024-09-06","current":34.79915,"twenty":17.848785,"median":24.36742,"eighty":31.120432,"marketCap":4444965081},{"date":"2024-09-13","current":35.404663,"twenty":17.848785,"median":24.435486,"eighty":31.286647,"marketCap":4522308383},{"date":"2024-09-20","current":37.834627,"twenty":17.848785,"median":24.535811,"eighty":31.405188,"marketCap":4832692616},{"date":"2024-09-27","current":37.620917,"twenty":17.848785,"median":24.628464,"eighty":31.548301,"marketCap":4805394980},{"date":"2024-10-04","current":36.576111,"twenty":17.848785,"median":24.693686,"eighty":31.671335,"marketCap":4671939870},{"date":"2024-10-11","current":36.342613,"twenty":17.848785,"median":24.776362,"eighty":31.921404,"marketCap":4642114675},{"date":"2024-10-18","current":39.372812,"twenty":17.848785,"median":24.882576,"eighty":32.212468,"marketCap":5325566602},{"date":"2024-10-25","current":37.545256,"twenty":17.848785,"median":25.007411,"eighty":32.383174,"marketCap":5078371341},{"date":"2024-10-31","current":37.732123,"twenty":17.848785,"median":25.038793,"eighty":32.531573,"marketCap":5103646930},{"date":"2024-11-08","current":38.195552,"twenty":17.848309,"median":25.036169,"eighty":32.647241,"marketCap":5166330391},{"date":"2024-11-15","current":37.647327,"twenty":17.848309,"median":25.05345,"eighty":32.844946,"marketCap":5092177385},{"date":"2024-11-22","current":38.12203,"twenty":17.848309,"median":25.05345,"eighty":32.996976,"marketCap":5156385738},{"date":"2024-11-29","current":39.120028,"twenty":17.848309,"median":25.05345,"eighty":33.070314,"marketCap":5291374952},{"date":"2024-12-06","current":37.834218,"twenty":17.848309,"median":25.05345,"eighty":33.177608,"marketCap":5117456264},{"date":"2024-12-13","current":37.6249,"twenty":17.848309,"median":25.05345,"eighty":33.254869,"marketCap":5089143920},{"date":"2024-12-20","current":33.890817,"twenty":17.848309,"median":25.143514,"eighty":33.332395,"marketCap":4584071917},{"date":"2024-12-27","current":35.344829,"twenty":17.848309,"median":25.20584,"eighty":33.433016,"marketCap":4780741596},{"date":"2025-01-03","current":34.152464,"twenty":17.848309,"median":25.316828,"eighty":33.484887,"marketCap":4619462348},{"date":"2025-01-10","current":33.449754,"twenty":17.847833,"median":25.412351,"eighty":33.512931,"marketCap":4524413763},{"date":"2025-01-17","current":32.918984,"twenty":17.847833,"median":25.627156,"eighty":33.512931,"marketCap":4452621747},{"date":"2025-01-24","current":29.843666,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4514302211},{"date":"2025-01-31","current":29.689919,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4491045643},{"date":"2025-02-07","current":29.850351,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4515313366},{"date":"2025-02-14","current":28.209267,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4267074775},{"date":"2025-02-21","current":28.924526,"twenty":17.847833,"median":25.682916,"eighty":33.512931,"marketCap":4375268377},{"date":"2025-02-28","current":29.116429,"twenty":17.847833,"median":25.724336,"eighty":33.512931,"marketCap":4404296702},{"date":"2025-03-07","current":28.988386,"twenty":17.846293,"median":25.852331,"eighty":33.522419,"marketCap":4384928194},{"date":"2025-03-14","current":25.446971,"twenty":17.849737,"median":25.966294,"eighty":33.522419,"marketCap":3849236048},{"date":"2025-03-21","current":26.589254,"twenty":17.892782,"median":26.105931,"eighty":33.522419,"marketCap":4022023524},{"date":"2025-03-28","current":26.946428,"twenty":17.939383,"median":26.181536,"eighty":33.522419,"marketCap":4076051467},{"date":"2025-04-04","current":25.986102,"twenty":17.978554,"median":26.303934,"eighty":33.522419,"marketCap":3930787659},{"date":"2025-04-11","current":24.851655,"twenty":18.014155,"median":26.294159,"eighty":33.512931,"marketCap":3759185663},{"date":"2025-04-17","current":23.983353,"twenty":18.072738,"median":26.294159,"eighty":33.512931,"marketCap":3766321745},{"date":"2025-04-25","current":24.944115,"twenty":18.128761,"median":26.303934,"eighty":33.522419,"marketCap":3917198891},{"date":"2025-05-02","current":24.905165,"twenty":18.128761,"median":26.303934,"eighty":33.522419,"marketCap":3911082250},{"date":"2025-05-09","current":25.957204,"twenty":18.128761,"median":26.303934,"eighty":33.522419,"marketCap":4076293393},{"date":"2025-05-16","current":27.109631,"twenty":18.128761,"median":26.362523,"eighty":33.522419,"marketCap":4257269401},{"date":"2025-05-23","current":24.694404,"twenty":18.128761,"median":26.401469,"eighty":33.522419,"marketCap":3877984472},{"date":"2025-05-30","current":25.145636,"twenty":18.128761,"median":26.401469,"eighty":33.522419,"marketCap":3948845501},{"date":"2025-06-05","current":24.587277,"twenty":18.128761,"median":26.362523,"eighty":33.522419,"marketCap":3861161351}],"updateTime":1749258772824}}}